John L. Wallace

Founder at Antibe Therapeutics, Inc.

John L. Wallace

John L. Wallace

Founder at Antibe Therapeutics, Inc.

Overview
Career Highlights

Canadian Association of Gastroenterology
Antibe Therapeutics, Inc.
NicOx SA

RelSci Relationships

249

Number of Boards

3

Birthday

1957

Age

63

Contact Data
Trying to get in touch with John L. Wallace? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals John L. Wallace likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Antibe Holdings, Inc.

Relationship likelihood: Strong

Professor at St. Bartholomew's Hospital

Relationship likelihood: Strong

Former President of International Markets at MasterCard, Inc.

Relationship likelihood: Strong

Director & President at Knight Therapeutics, Inc.

Relationship likelihood: Strong

President at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Chief Executive Officer at MaRS Discovery District

Relationship likelihood: Strong

Chief Executive Officer & Director at Knight Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Antibe Therapeutics, Inc.

Relationship likelihood: Strong

Chief Development Officer at Antibe Therapeutics, Inc.

Relationship likelihood: Strong

Former Interim Vice President (Research) at University of Calgary

Relationship likelihood: Strong

Paths to John L. Wallace
Potential Connections via
Relationship Science
You
John L. Wallace
Founder at Antibe Therapeutics, Inc.
Education
MBA International Business
Class of 2007

Birmingham has been challenging and developing great minds for more than a century. Characterised by a tradition of innovation, research at the University has broken new ground, pushed forward the boundaries of knowledge and made an impact on people’s lives. We continue this tradition today and have ambitions for a future that will embed our work and recognition of the Birmingham name on the international stage. Universities are never complete. They develop as new challenges and opportunities occur. At Birmingham we innovate, we push the frontiers of understanding; we ask new research questions, we turn theory through experiment into practice – because that’s what great universities do.

PhD in Medical Sciences
Class of 1983

Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.

M.S. in Biological Sciences
Class of 1980

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Career History
Founder
2009 - Current

Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the Antibe Therapeutics, and Citagenix segments. The Antibe Therapeutics segment focuses on the development of pharmaceutical products. The Citagenix segment involves in the development and sale of regenerative medicines serving the dental and orthopedic market places. The company was founded by Andre Buret, John Wallace and Giuseppe Cirino on May 5, 2009 and is headquartered in Toronto, Canada.

Professor
2009 - Current

McMaster University is a public research university located in Hamilton, Ontario, Canada. The main campus is located on 121 hectares (300 acres) of land near the residential neighbourhoods of Ainslie Wood and Westdale, adjacent to Hamilton's Royal Botanical Gardens. McMaster was controlled by the Baptist Convention of Ontario and Quebec until it became a privately chartered, publicly funded non-denominational institution in 1957. The university is co-educational, and has over 25,000 undergraduate and over 4,000 post-graduate students

Chairman & Chief Scientific Officer
Current

Antibe Holdings, Inc. is a private company headquartered in Toronto, ON, Canada. The firm functions as an investment holding company. Daniel Legault is the CEO, in this role since 2005.

Boards & Committees
Chairman & Chief Scientific Officer
Current

Antibe Holdings, Inc. is a private company headquartered in Toronto, ON, Canada. The firm functions as an investment holding company. Daniel Legault is the CEO, in this role since 2005.

Director
Current

Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.

Investments
Details Hidden

Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the Antibe Therapeutics, and Citagenix segments. The Antibe Therapeutics segment focuses on the development of pharmaceutical products. The Citagenix segment involves in the development and sale of regenerative medicines serving the dental and orthopedic market places. The company was founded by Andre Buret, John Wallace and Giuseppe Cirino on May 5, 2009 and is headquartered in Toronto, Canada.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John L. Wallace. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John L. Wallace's profile does not indicate a business or promotional relationship of any kind between RelSci and John L. Wallace.